Wegovy vs Ozempic: Same Drug? Switch Guide | Cured

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy and Ozempic - UK Price From £69.00

Get the cheapest UK price on Wegovy from £69.00 with £20 off your first order using code WEIGHTLOSSNEW.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off first order using code WEIGHTLOSSNEW

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Understanding Semaglutide: Wegovy vs Ozempic in the UK

Published on: June 03, 2026

Many UK patients ask whether Wegovy and Ozempic the same UK medication, and the answer is both yes and no. Whilst both contain the active ingredient semaglutide, they're licensed for different purposes and formulated at different maximum doses. At Cured Pharmacy, our UK-registered clinical team helps patients understand which semaglutide option suits their needs, with Wegovy available from £79.00 following a free online consultation.

Are Wegovy and Ozempic the Same Medication?

Wegovy and Ozempic both contain semaglutide, a GLP-1 receptor agonist that mimics the action of the naturally occurring hormone glucagon-like peptide-1 [1]. This shared active ingredient means they work through identical mechanisms—slowing gastric emptying, reducing appetite, and improving glycaemic control. However, the MHRA has licensed these products for distinctly different indications in the UK.

Ozempic received UK marketing authorisation specifically for type 2 diabetes management, with approved doses ranging from 0.25mg to 2mg weekly [2]. Wegovy, conversely, is licensed exclusively for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities, escalating to a maximum maintenance dose of 2.4mg weekly [1]. This higher dose ceiling represents the key pharmaceutical difference between the two formulations.

Whilst the active pharmaceutical ingredient remains identical, prescribing Ozempic off-label for weight loss—a practice that became widespread during Wegovy supply shortages—raises regulatory and safety considerations. The MHRA and NHS England have issued guidance emphasising that clinicians should prescribe medications within their licensed indications wherever possible, particularly given that Wegovy's clinical trial programme specifically evaluated safety and efficacy at the higher 2.4mg dose for weight management [3].

Clinical Evidence: Wegovy and Ozempic Weight Loss Outcomes

The STEP clinical trial programme established Wegovy's efficacy specifically for weight management. In the landmark STEP 1 trial, participants receiving semaglutide 2.4mg weekly achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. This represented the most significant weight loss outcome for any pharmaceutical intervention available at the time of publication.

Ozempic's pivotal trials—the SUSTAIN programme—focused primarily on glycaemic control in type 2 diabetes, though weight loss emerged as a consistent secondary outcome. At the 1mg dose, participants experienced average weight reductions of 4.5kg to 6.5kg across various SUSTAIN studies [2]. The 2mg Ozempic dose, approved more recently, demonstrated weight loss approaching but not matching the 2.4mg Wegovy outcomes, averaging approximately 7kg reduction in SUSTAIN FORTE [4].

These differing trial designs reflect the products' distinct regulatory purposes. Wegovy trials enrolled participants based on BMI criteria alone, without requiring diabetes diagnosis, and used weight reduction as the primary endpoint. Ozempic trials recruited exclusively type 2 diabetes patients and measured HbA1c reduction as the primary outcome, with weight loss assessed secondarily. This fundamental difference in study populations and endpoints means direct comparison requires careful interpretation.

Real-World Effectiveness Considerations

Beyond controlled trial environments, real-world evidence suggests adherence and dose escalation significantly influence outcomes with both formulations. UK prescribers report that patients who successfully titrate to and maintain the maximum licensed dose—whether 2mg Ozempic for diabetes or 2.4mg Wegovy for weight management—achieve superior results compared to those remaining at lower maintenance doses. Gastrointestinal tolerability during dose escalation represents the most common barrier to reaching target doses, affecting approximately 40-50% of patients to varying degrees [1][2].

Can You Switch from Ozempic to Wegovy in the UK?

Switching between Ozempic and Wegovy is medically straightforward when clinically appropriate, as both deliver the same active molecule. UK prescribers typically recommend transitioning patients who were initially prescribed Ozempic off-label for weight loss to the appropriately licensed Wegovy formulation, particularly if supply constraints have resolved. The switch requires clinical assessment to ensure the patient meets Wegovy's licensing criteria—specifically the BMI thresholds and absence of contraindications.

The practical switching process depends on your current Ozempic dose. If you're established on Ozempic 1mg weekly, your prescriber will likely continue that dose as the next Wegovy injection, then follow Wegovy's standard escalation schedule toward 2.4mg if tolerated and clinically indicated. Patients on Ozempic 2mg may transition directly to Wegovy 2mg, with consideration for the final step to 2.4mg after at least four weeks. No washout period is necessary given the identical active ingredient.

From a regulatory perspective, switching from off-label Ozempic use to licensed Wegovy represents best practice prescribing. NHS England's 2023 guidance on GLP-1 receptor agonists for weight management explicitly states that where both products are available, Wegovy should be the preferred choice for patients seeking treatment primarily for obesity rather than diabetes management [3]. At Cured Pharmacy, our UK prescribers assess switching requests individually, ensuring continuity of care whilst optimising treatment within licensed parameters.

Insurance and Prescription Considerations

Patients switching from Ozempic to Wegovy should note that prescription charges and private pricing structures may differ between the products, despite containing the same active ingredient. This reflects the separate marketing authorisations and, in some cases, different reimbursement frameworks. Our clinical team provides transparent pricing information before any prescription is issued, ensuring you understand the financial implications of switching between formulations.

Feature Wegovy Ozempic
Active Ingredient Semaglutide Semaglutide
UK Licensed Indication Chronic weight management Type 2 diabetes management
Maximum Dose 2.4mg weekly 2mg weekly
Dose Escalation Steps 5 steps over 16-20 weeks 3-4 steps over 12-16 weeks
Average Weight Loss (trials) 14.9% body weight (STEP 1) 4-7kg (SUSTAIN trials)
Starting Price at Cured From £69.00 Licensed for diabetes
Injection Frequency Once weekly Once weekly
Prescription Required Yes - UK prescriber assessment Yes - UK prescriber assessment

Wegovy vs Ozempic: Dosing Schedules and Administration

Both Wegovy and Ozempic utilise once-weekly subcutaneous injection via pre-filled, single-dose pens. The injection technique, storage requirements (refrigeration until first use), and administration sites (abdomen, thigh, or upper arm) remain identical across both products. This consistency means patients switching between formulations require no retraining on injection methodology.

The dose escalation schedules differ to accommodate each product's maximum licensed dose. Ozempic typically begins at 0.25mg weekly for four weeks (a dose intended to improve tolerability rather than provide therapeutic effect), increases to 0.5mg for at least four weeks, then to 1mg if additional glycaemic control is needed, with a possible further increase to 2mg [2]. Wegovy follows a more gradual five-step escalation: 0.25mg for four weeks, 0.5mg for four weeks, 1mg for four weeks, 1.7mg for four weeks, then the maintenance dose of 2.4mg [1].

The rationale for Wegovy's additional 1.7mg step relates to tolerability data from the STEP trials, which demonstrated that the extra escalation stage reduced discontinuation rates due to gastrointestinal adverse effects. UK prescribers may modify these standard schedules based on individual patient tolerance, occasionally extending time at intermediate doses or, in rare cases, maintaining patients at sub-maximal doses if the maximum dose proves intolerable despite producing adequate clinical response.

Cost Comparison: Wegovy and Ozempic Pricing in the UK

Pricing for semaglutide formulations varies significantly across UK pharmacies and depends heavily on dose strength and supply dynamics. At Cured Pharmacy, Wegovy is available from £79.00 following clinical assessment by our UK-registered prescribers—representing competitive UK pricing with transparent costs displayed before consultation. We guarantee the lowest prices in the UK market, with no hidden fees or surprise charges at checkout.

Ozempic pricing in the private market has historically been influenced by its dual use for both diabetes management and off-label weight loss, with demand fluctuations affecting availability. During periods when Wegovy faced supply constraints across UK pharmacies, Ozempic prescriptions for weight management increased substantially, occasionally creating access challenges for diabetes patients—the medication's primary licensed population. The MHRA and NHS England responded by issuing prescribing guidance to prioritise diabetes patients for Ozempic supplies.

When comparing costs between the two formulations, patients should consider the licensed maximum doses and treatment duration required to achieve clinical goals. Wegovy's 2.4mg maintenance dose represents the evidence-based target for optimal weight loss outcomes, whereas Ozempic's diabetes-focused licensing means the 2mg maximum may deliver less pronounced weight reduction. Our clinical team discusses cost-effectiveness alongside clinical suitability during your free online consultation, ensuring treatment decisions balance efficacy, safety, and affordability.

Understanding What's Included in Your Prescription Cost

At Cured Pharmacy, the price you see includes the medication, UK prescriber consultation, and discreet delivery to your address. There are no additional consultation fees or hidden prescription charges. Your treatment plan includes ongoing support from our UK-registered clinical team, with straightforward processes for prescription renewals, dose adjustments, or switching between formulations if clinically appropriate. All pricing is confirmed upfront before you complete your clinical assessment, ensuring complete transparency throughout your treatment journey.

Safety Profile: Side Effects and Contraindications

Given their shared active ingredient, Wegovy and Ozempic present virtually identical safety profiles and contraindication lists. The most frequently reported adverse effects are gastrointestinal: nausea affects approximately 44% of patients during dose escalation, with diarrhoea, constipation, and vomiting also common [1][2]. These effects typically diminish over 4-8 weeks as the body adapts to each new dose level, though a subset of patients experiences persistent symptoms requiring dose reduction or discontinuation.

Both medications carry important contraindications that UK prescribers must assess before prescribing. Personal or family history of medullary thyroid carcinoma represents an absolute contraindication, as does multiple endocrine neoplasia syndrome type 2, based on rodent study findings of thyroid C-cell tumours [1][2]. Patients with a history of pancreatitis require careful risk-benefit evaluation, as GLP-1 receptor agonists have been associated with acute pancreatitis in post-marketing surveillance, though causality remains debated in the medical literature.

Pregnancy and breastfeeding represent additional contraindications for both formulations. Semaglutide should be discontinued at least two months before planned conception due to its long half-life of approximately one week and limited human pregnancy data [1]. Women of childbearing potential should use effective contraception during treatment. UK prescribers at Cured Pharmacy conduct thorough medical history reviews during your online consultation to identify any contraindications or precautions specific to your circumstances, ensuring safe prescribing practices in line with MHRA guidance.

Monitoring Requirements During Treatment

Patients using either Wegovy or Ozempic should be monitored for signs of acute pancreatitis—persistent severe abdominal pain that may radiate to the back—and instructed to discontinue treatment immediately if this occurs. Regular review of weight loss progress, tolerability, and any emerging side effects should occur every 12-16 weeks, with treatment discontinued if insufficient response is achieved. Our clinical team at Cured Pharmacy provides ongoing support throughout your treatment journey, with straightforward access to UK prescribers if concerns arise between scheduled reviews.

Scientific References

  1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  2. Sorli, C., et al. (2017). Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial. The Lancet Diabetes & Endocrinology, 5(4), 251–260. https://doi.org/10.1016/S2213-8587(17)30013-X [accessed 13 August 2026]
  3. NHS England. (2023). Clinical Commissioning Policy: Semaglutide for weight management. NHS England. [accessed 13 August 2026]
  4. Frías, J. P., et al. (2021). Efficacy and safety of once-weekly semaglutide 2.0 mg versus 1.0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3b trial. The Lancet Diabetes & Endocrinology, 9(9), 563–574. https://doi.org/10.1016/S2213-8587(21)00174-1 [accessed 13 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy and Ozempic are prescription-only medicines containing semaglutide. Individual results may vary. Treatment outcomes described reflect average results from clinical trials and may not be representative of all patients. Side effects can occur—discuss risks and benefits with your prescriber.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Are Wegovy and Ozempic the same drug?
Yes, both contain semaglutide as the active ingredient, but they're licensed for different purposes—Wegovy for weight management at up to 2.4mg weekly, and Ozempic for type 2 diabetes at up to 2mg weekly. The higher Wegovy dose was specifically studied for weight loss in the STEP clinical trials.
Can I use Ozempic instead of Wegovy for weight loss in the UK?
Ozempic is licensed exclusively for type 2 diabetes management in the UK, though some prescribers may use it off-label for weight loss. NHS England guidance recommends using Wegovy—the appropriately licensed formulation—for patients seeking weight management treatment.
How do I switch from Ozempic to Wegovy?
Switching requires a clinical assessment with a UK prescriber to confirm you meet Wegovy's licensing criteria. If you're on Ozempic 1mg, you'd typically continue at that dose with Wegovy, then escalate toward 2.4mg following the standard schedule. No washout period is needed as both contain identical semaglutide.
Which is more effective for weight loss: Wegovy or Ozempic?
Clinical trials show Wegovy at 2.4mg produces greater average weight loss (14.9% body weight) than Ozempic at diabetes-approved doses (4-7kg average reduction). This reflects both the higher maximum dose and Wegovy's specific development for weight management.
Do Wegovy and Ozempic have the same side effects?
Yes, both share virtually identical safety profiles as they contain the same active ingredient. Gastrointestinal effects—particularly nausea, diarrhoea, and constipation—are most common, affecting up to 44% of patients during dose escalation.
Why are Wegovy and Ozempic priced differently if they're the same drug?
Despite containing the same active ingredient, they have separate marketing authorisations, different maximum doses, and distinct supply chains. Pricing reflects these factors alongside market demand for each indication. At Cured Pharmacy, Wegovy starts from £79.00 with transparent upfront pricing.
Can I get Wegovy on the NHS instead of paying privately?
NHS England has approved Wegovy for specialist weight management services in limited circumstances, typically through tier 3 or tier 4 obesity services with strict eligibility criteria and lengthy waiting lists. Private prescription through registered UK pharmacies like Cured offers faster access subject to clinical assessment.
How long does Wegovy or Ozempic treatment typically last?
Both are intended for long-term use as chronic disease management. Clinical guidelines suggest continuing treatment as long as it remains effective and well-tolerated, with regular reviews every 12-16 weeks. Discontinuing treatment often results in weight regain, so ongoing use is typically necessary to maintain benefits.
Are Wegovy and Ozempic the same medication in the UK?
Wegovy and Ozempic both contain the same active ingredient, semaglutide, but they are licensed for different purposes in the UK. Ozempic is approved for type 2 diabetes management, while Wegovy is specifically licensed for weight loss in adults with obesity or weight-related health conditions. Cured Pharmacy offers Wegovy with full prescriber consultation to ensure it's the right treatment for your weight management goals.
Can I switch from Ozempic to Wegovy in the UK?
Yes, many patients switch from Ozempic to Wegovy under medical supervision, especially if their primary goal is weight loss rather than diabetes control. Your prescriber will assess your medical history and current dose to ensure a safe transition. Cured Pharmacy's UK-registered clinicians can guide you through switching from Ozempic to Wegovy at the cheapest UK price from £69.00.
Why is Wegovy more expensive than Ozempic in the UK?
Wegovy is typically priced higher than Ozempic because it's licensed specifically for weight management and comes in higher maintenance doses up to 2.4mg. However, Cured Pharmacy offers Wegovy at the cheapest UK price starting from £69.00, with an additional £20 off your first order using code WEIGHTLOSSNEW. Both medications contain semaglutide but are prescribed for different clinical purposes.
Is Wegovy available on the NHS or only privately in the UK?
Wegovy is available on the NHS but with very strict eligibility criteria and long waiting lists in most areas of the UK. Private pharmacies like Cured Pharmacy offer faster access with next-day delivery options and competitive pricing from £69.00. Our UK-registered prescribers conduct full consultations to ensure Wegovy is clinically appropriate for you.
Do Wegovy and Ozempic have the same side effects in the UK?
Yes, because Wegovy and Ozempic contain the same active ingredient (semaglutide), they share similar side effects including nausea, diarrhoea, and reduced appetite. The side effect profile is comparable regardless of whether the medication is marketed as Ozempic or Wegovy. Cured Pharmacy provides full clinical support and guidance on managing any side effects throughout your treatment journey.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.